Copyright Reports & Markets. All rights reserved.

Global Genetically Modified Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Genetically Modified Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Transgenic Animal
    • 1.3.3 Transgenic Plant
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Genetically Modified Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Genetically Modified Drug Market Size & Forecast
    • 1.5.1 Global Genetically Modified Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Genetically Modified Drug Sales Quantity (2021-2032)
    • 1.5.3 Global Genetically Modified Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 LFB Biotechnologies SA
    • 2.1.1 LFB Biotechnologies SA Details
    • 2.1.2 LFB Biotechnologies SA Major Business
    • 2.1.3 LFB Biotechnologies SA Genetically Modified Drug Product and Services
    • 2.1.4 LFB Biotechnologies SA Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 LFB Biotechnologies SA Recent Developments/Updates
  • 2.2 Pharming Group NV
    • 2.2.1 Pharming Group NV Details
    • 2.2.2 Pharming Group NV Major Business
    • 2.2.3 Pharming Group NV Genetically Modified Drug Product and Services
    • 2.2.4 Pharming Group NV Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pharming Group NV Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Genetically Modified Drug Product and Services
    • 2.3.4 Pfizer Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche Genetically Modified Drug Product and Services
    • 2.4.4 Roche Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Roche Recent Developments/Updates
  • 2.5 Abbott Laboratories
    • 2.5.1 Abbott Laboratories Details
    • 2.5.2 Abbott Laboratories Major Business
    • 2.5.3 Abbott Laboratories Genetically Modified Drug Product and Services
    • 2.5.4 Abbott Laboratories Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abbott Laboratories Recent Developments/Updates
  • 2.6 Johnson & Johnson
    • 2.6.1 Johnson & Johnson Details
    • 2.6.2 Johnson & Johnson Major Business
    • 2.6.3 Johnson & Johnson Genetically Modified Drug Product and Services
    • 2.6.4 Johnson & Johnson Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Johnson & Johnson Recent Developments/Updates
  • 2.7 Merck & Co.
    • 2.7.1 Merck & Co. Details
    • 2.7.2 Merck & Co. Major Business
    • 2.7.3 Merck & Co. Genetically Modified Drug Product and Services
    • 2.7.4 Merck & Co. Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck & Co. Recent Developments/Updates
  • 2.8 Amgen
    • 2.8.1 Amgen Details
    • 2.8.2 Amgen Major Business
    • 2.8.3 Amgen Genetically Modified Drug Product and Services
    • 2.8.4 Amgen Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Amgen Recent Developments/Updates
  • 2.9 F. Hoffmann-La Roche
    • 2.9.1 F. Hoffmann-La Roche Details
    • 2.9.2 F. Hoffmann-La Roche Major Business
    • 2.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product and Services
    • 2.9.4 F. Hoffmann-La Roche Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 F. Hoffmann-La Roche Recent Developments/Updates
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Genetically Modified Drug Product and Services
    • 2.10.4 Sanofi Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sanofi Recent Developments/Updates
  • 2.11 Novartis
    • 2.11.1 Novartis Details
    • 2.11.2 Novartis Major Business
    • 2.11.3 Novartis Genetically Modified Drug Product and Services
    • 2.11.4 Novartis Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Novartis Recent Developments/Updates
  • 2.12 Eli Lilly
    • 2.12.1 Eli Lilly Details
    • 2.12.2 Eli Lilly Major Business
    • 2.12.3 Eli Lilly Genetically Modified Drug Product and Services
    • 2.12.4 Eli Lilly Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Eli Lilly Recent Developments/Updates
  • 2.13 Takeda
    • 2.13.1 Takeda Details
    • 2.13.2 Takeda Major Business
    • 2.13.3 Takeda Genetically Modified Drug Product and Services
    • 2.13.4 Takeda Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Takeda Recent Developments/Updates
  • 2.14 Baxter
    • 2.14.1 Baxter Details
    • 2.14.2 Baxter Major Business
    • 2.14.3 Baxter Genetically Modified Drug Product and Services
    • 2.14.4 Baxter Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Baxter Recent Developments/Updates
  • 2.15 GlaxoSmithKline
    • 2.15.1 GlaxoSmithKline Details
    • 2.15.2 GlaxoSmithKline Major Business
    • 2.15.3 GlaxoSmithKline Genetically Modified Drug Product and Services
    • 2.15.4 GlaxoSmithKline Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 GlaxoSmithKline Recent Developments/Updates

3 Competitive Environment: Genetically Modified Drug by Manufacturer

  • 3.1 Global Genetically Modified Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Genetically Modified Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global Genetically Modified Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Genetically Modified Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Genetically Modified Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Genetically Modified Drug Manufacturer Market Share in 2025
  • 3.5 Genetically Modified Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Genetically Modified Drug Market: Region Footprint
    • 3.5.2 Genetically Modified Drug Market: Company Product Type Footprint
    • 3.5.3 Genetically Modified Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Genetically Modified Drug Market Size by Region
    • 4.1.1 Global Genetically Modified Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Genetically Modified Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global Genetically Modified Drug Average Price by Region (2021-2032)
  • 4.2 North America Genetically Modified Drug Consumption Value (2021-2032)
  • 4.3 Europe Genetically Modified Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Genetically Modified Drug Consumption Value (2021-2032)
  • 4.5 South America Genetically Modified Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Genetically Modified Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Genetically Modified Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global Genetically Modified Drug Consumption Value by Type (2021-2032)
  • 5.3 Global Genetically Modified Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Genetically Modified Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global Genetically Modified Drug Consumption Value by Application (2021-2032)
  • 6.3 Global Genetically Modified Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Genetically Modified Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America Genetically Modified Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America Genetically Modified Drug Market Size by Country
    • 7.3.1 North America Genetically Modified Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Genetically Modified Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Genetically Modified Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe Genetically Modified Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe Genetically Modified Drug Market Size by Country
    • 8.3.1 Europe Genetically Modified Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Genetically Modified Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Genetically Modified Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Genetically Modified Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Genetically Modified Drug Market Size by Region
    • 9.3.1 Asia-Pacific Genetically Modified Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Genetically Modified Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Genetically Modified Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America Genetically Modified Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America Genetically Modified Drug Market Size by Country
    • 10.3.1 South America Genetically Modified Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Genetically Modified Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Genetically Modified Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Genetically Modified Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Genetically Modified Drug Market Size by Country
    • 11.3.1 Middle East & Africa Genetically Modified Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Genetically Modified Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Genetically Modified Drug Market Drivers
  • 12.2 Genetically Modified Drug Market Restraints
  • 12.3 Genetically Modified Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Genetically Modified Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Genetically Modified Drug
  • 13.3 Genetically Modified Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Genetically Modified Drug Typical Distributors
  • 14.3 Genetically Modified Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Genetically Modified Drug market size was valued at US$ 2805 million in 2025 and is forecast to a readjusted size of US$ 4161 million by 2032 with a CAGR of 5.9% during review period.
    Drugs made by genetically modified means are also called "biological drugs"
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Genetically Modified Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Genetically Modified Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Genetically Modified Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Genetically Modified Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Genetically Modified Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Genetically Modified Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Genetically Modified Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen, F. Hoffmann-La Roche, Sanofi, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Genetically Modified Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Transgenic Animal
    Transgenic Plant
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    LFB Biotechnologies SA
    Pharming Group NV
    Pfizer
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Merck & Co.
    Amgen
    F. Hoffmann-La Roche
    Sanofi
    Novartis
    Eli Lilly
    Takeda
    Baxter
    GlaxoSmithKline
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Genetically Modified Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Genetically Modified Drug, with price, sales quantity, revenue, and global market share of Genetically Modified Drug from 2021 to 2026.
    Chapter 3, the Genetically Modified Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Genetically Modified Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Genetically Modified Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Genetically Modified Drug.
    Chapter 14 and 15, to describe Genetically Modified Drug sales channel, distributors, customers, research findings and conclusion.

    Buy now